Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 283

1.

[Medical care of young women with Turner syndrome in Germany].

Dörr HG, Bettendorf M, Binder G, Brämswig J, Hauffa BP, Holterhus PM, Mohnike K, Schmidt H, Stalla GK, Wabitsch M, Wölfle J; und die Turner-Syndrom-Vereinigung Deutschland e. V.

Dtsch Med Wochenschr. 2019 Jul 24. doi: 10.1055/a-0923-4191. [Epub ahead of print] German.

2.

Quality of Life of Short-Statured Children Born Small for Gestational Age or Idiopathic Growth Hormone Deficiency Within 1 Year of Growth Hormone Treatment.

Quitmann J, Bloemeke J, Silva N, Bullinger M, Witt S, Akkurt I, Dunstheimer D, Vogel C, Böttcher V, Kuhnle Krahl U, Bettendorf M, Schönau E, Fricke-Otto S, Keller A, Mohnike K, Dörr HG.

Front Pediatr. 2019 Apr 29;7:164. doi: 10.3389/fped.2019.00164. eCollection 2019.

3.

Psychometric properties of the quality of life in short statured youth (QoLISSY) questionnaire within the course of growth hormone treatment.

Bloemeke J, Silva N, Bullinger M, Witt S, Dörr HG, Quitmann J.

Health Qual Life Outcomes. 2019 Mar 18;17(1):49. doi: 10.1186/s12955-019-1118-9.

4.

[Life Situation of Young women with Turner Syndrome: Results of a Questionnaire-based Study in Germany].

Dörr HG, Bettendorf M, Binder G, Brämswig J, Hauffa BP, Holterhus PM, Mohnike K, Schmidt H, Stalla GK, Wabitsch M, Wölfle J; und die Turner-Syndrom-Vereinigung Deutschland e. V.; Geschäftsstelle: Am Bornstück 1, Dornburg.

Dtsch Med Wochenschr. 2019 Jul;144(14):e87-e93. doi: 10.1055/a-0841-9918. Epub 2019 Mar 14. German.

5.

First-year predictors of health-related quality of life changes in short-statured children treated with human growth hormone.

Quitmann J, Bloemeke J, Dörr HG, Bullinger M, Witt S, Silva N.

J Endocrinol Invest. 2019 Sep;42(9):1067-1076. doi: 10.1007/s40618-019-01027-4. Epub 2019 Mar 6.

PMID:
30840207
6.

Adrenarche and pubarche in girls with turner syndrome during growth-promoting therapy with human growth hormone.

Dörr HG, Penger T, Marx M, Rauh M, Oppelt PG, Völkl TKM.

BMC Endocr Disord. 2019 Jan 18;19(1):9. doi: 10.1186/s12902-019-0333-z.

7.

Genotype/phenotype correlations in 538 congenital adrenal hyperplasia patients from Germany and Austria: discordances in milder genotypes and in screened versus prescreening patients.

Riedl S, Röhl FW, Bonfig W, Brämswig J, Richter-Unruh A, Fricke-Otto S, Bettendorf M, Riepe F, Kriegshäuser G, Schönau E, Even G, Hauffa B, Dörr HG, Holl RW, Mohnike K; AQUAPE CAH Study Group.

Endocr Connect. 2019 Feb 1;8(2):86-94. doi: 10.1530/EC-18-0281.

8.

Miscarriages in families with an offspring that have classic congenital adrenal hyperplasia and 21-hydroxylase deficiency.

Dörr HG, Hess J, Penger T, Marx M, Oppelt P.

BMC Pregnancy Childbirth. 2018 Nov 23;18(1):456. doi: 10.1186/s12884-018-2091-8.

9.

Birth Size in Neonates with Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency

Dörr HG, Penger T, Albrecht A, Marx M, Völkl TMK.

J Clin Res Pediatr Endocrinol. 2019 Feb 20;11(1):41-45. doi: 10.4274/jcrpe.galenos.2018.2018.0149. Epub 2018 Sep 4.

10.

Epigenetic Repression of Androgen Receptor Transcription in Mutation-Negative Androgen Insensitivity Syndrome (AIS Type II).

Hornig NC, Rodens P, Dörr H, Hubner NC, Kulle AE, Schweikert HU, Welzel M, Bens S, Hiort O, Werner R, Gonzalves S, Eckstein AK, Cools M, Verrijn-Stuart A, Stunnenberg HG, Siebert R, Ammerpohl O, Holterhus PM.

J Clin Endocrinol Metab. 2018 Dec 1;103(12):4617-4627. doi: 10.1210/jc.2018-00052.

PMID:
30124873
11.

Adrenal crisis in a 14-year-old boy 12 years after hematopoietic stem cell transplantation.

Penger T, Albrecht A, Marx M, Stachel D, Metzler M, Dörr HG.

Endocrinol Diabetes Metab Case Rep. 2018 Jun 6;2018. pii: EDM180034. doi: 10.1530/EDM-18-0034. eCollection 2018.

12.

Mortality in children with classic congenital adrenal hyperplasia and 21-hydroxylase deficiency (CAH) in Germany.

Dörr HG, Wollmann HA, Hauffa BP, Woelfle J; German Society of Pediatric Endocrinology and Diabetology.

BMC Endocr Disord. 2018 Jun 8;18(1):37. doi: 10.1186/s12902-018-0263-1.

13.

Immunological Markers of Chronic Occupational Radiation Exposure.

Rybkina VL, Bannikova MV, Adamova GV, Dörr H, Scherthan H, Azizova TV.

Health Phys. 2018 Jul;115(1):108-113. doi: 10.1097/HP.0000000000000855.

PMID:
29787436
14.

Clinical relevance of systematic phenotyping and exome sequencing in patients with short stature.

Hauer NN, Popp B, Schoeller E, Schuhmann S, Heath KE, Hisado-Oliva A, Klinger P, Kraus C, Trautmann U, Zenker M, Zweier C, Wiesener A, Abou Jamra R, Kunstmann E, Wieczorek D, Uebe S, Ferrazzi F, Büttner C, Ekici AB, Rauch A, Sticht H, Dörr HG, Reis A, Thiel CT.

Genet Med. 2018 Jun;20(6):630-638. doi: 10.1038/gim.2017.159. Epub 2017 Oct 12.

15.

Correlation of Radiation Dose Estimates by DIC with the METREPOL Hematological Classes of Disease Severity.

Port M, Pieper B, Dörr HD, Hübsch A, Majewski M, Abend M.

Radiat Res. 2018 May;189(5):449-455. doi: 10.1667/RR14936.1. Epub 2018 Mar 1.

PMID:
29494324
16.

Short-term adverse effects of testosterone used for priming in prepubertal boys before growth hormone stimulation test.

Albrecht A, Penger T, Marx M, Hirsch K, Dörr HG.

J Pediatr Endocrinol Metab. 2018 Jan 26;31(1):21-24. doi: 10.1515/jpem-2017-0280.

PMID:
29197861
17.

Sodium Chloride Supplementation Is Not Routinely Performed in the Majority of German and Austrian Infants with Classic Salt-Wasting Congenital Adrenal Hyperplasia and Has No Effect on Linear Growth and Hydrocortisone or Fludrocortisone Dose.

Bonfig W, Roehl F, Riedl S, Brämswig J, Richter-Unruh A, Fricke-Otto S, Hübner A, Bettendorf M, Schönau E, Dörr H, Holl RW, Mohnike K.

Horm Res Paediatr. 2018;89(1):7-12. doi: 10.1159/000481775. Epub 2017 Oct 26.

PMID:
29073619
18.

Genetic screening confirms heterozygous mutations in ACAN as a major cause of idiopathic short stature.

Hauer NN, Sticht H, Boppudi S, Büttner C, Kraus C, Trautmann U, Zenker M, Zweier C, Wiesener A, Jamra RA, Wieczorek D, Kelkel J, Jung AM, Uebe S, Ekici AB, Rohrer T, Reis A, Dörr HG, Thiel CT.

Sci Rep. 2017 Sep 22;7(1):12225. doi: 10.1038/s41598-017-12465-6.

19.

Intrauterine Growth Restriction (IUGR) Induces Signs of Subclinical Atherosclerosis in 6-Year-Old Infants Despite Absence Of Excessive Growth.

Tzschoppe A, von Kries R, Struwe E, Rascher W, Dörr HG, Jüngert J, Rauh M, Beckmann M, Schild R, Goecke TW, Dötsch J.

Klin Padiatr. 2017 Jul;229(4):209-215. doi: 10.1055/s-0043-104528. Epub 2017 Jul 17.

PMID:
28718186
20.

Rapid Prediction of Hematologic Acute Radiation Syndrome in Radiation Injury Patients Using Peripheral Blood Cell Counts.

Port M, Pieper B, Knie T, Dörr H, Ganser A, Graessle D, Meineke V, Abend M.

Radiat Res. 2017 Aug;188(2):156-168. doi: 10.1667/RR14612.1. Epub 2017 Jun 7.

PMID:
28590841
21.

Using Clinical Signs and Symptoms for Medical Management of Radiation Casualties - 2015 NATO Exercise.

Dörr H, Abend M, Blakely WF, Bolduc DL, Boozer D, Costeira T, Dant T, De Amicis A, De Sanctis S, Dondey M, Drouet M, Entine F, Francois S, Gagna G, Guitard N, Hérodin F, Hoefer M, Lamkowski A, La Sala G, Lista F, Loiacono P, Majewski M, Martigne P, Métivier D, Michel X, Pateux J, Pejchal J, Reeves G, Riccobono D, Sinkorova Z, Soyez L, Stricklin D, Tichy A, Valente M, Woodruff CR Jr, Zarybnicka L, Port M.

Radiat Res. 2017 Mar;187(3):273-286. doi: 10.1667/RR14619.1. Epub 2017 Feb 20.

PMID:
28218888
22.

Variable White Matter Atrophy and Intellectual Development in a Family With X-linked Creatine Transporter Deficiency Despite Genotypic Homogeneity.

Heussinger N, Saake M, Mennecke A, Dörr HG, Trollmann R.

Pediatr Neurol. 2017 Feb;67:45-52. doi: 10.1016/j.pediatrneurol.2016.10.007. Epub 2016 Oct 17.

PMID:
28065824
23.

Diffuse Encephalopathy Associated with Isolated Cerebral Langerhans Cell Histiocytosis.

Rompel O, Buslei R, Hammon M, Dörr HG, Chada M, Nikkhah G, Uder M, Trollmann R.

Pediatr Neurol. 2016 Sep;62:62-5. doi: 10.1016/j.pediatrneurol.2016.05.006. Epub 2016 May 11.

PMID:
27426422
24.

GENETICS IN ENDOCRINOLOGY: Gain and loss of function mutations of the calcium-sensing receptor and associated proteins: current treatment concepts.

Mayr B, Schnabel D, Dörr HG, Schöfl C.

Eur J Endocrinol. 2016 May;174(5):R189-208. doi: 10.1530/EJE-15-1028. Epub 2015 Dec 8. Review.

PMID:
26646938
25.

Experts' Opinion on the Prenatal Therapy of Congenital Adrenal Hyperplasia (CAH) Due to 21-Hydroxylase Deficiency - Guideline of DGKED in cooperation with DGGG (S1-Level, AWMF Registry No. 174/013, July 2015).

Dörr HG, Binder G, Reisch N, Gembruch U, Oppelt PG, Wieacker P, Kratzsch J.

Geburtshilfe Frauenheilkd. 2015 Dec;75(12):1232-1238. doi: 10.1055/s-0041-109717.

26.

Children with classic congenital adrenal hyperplasia experience salt loss and hypoglycemia: evaluation of adrenal crises during the first 6 years of life.

Odenwald B, Nennstiel-Ratzel U, Dörr HG, Schmidt H, Wildner M, Bonfig W.

Eur J Endocrinol. 2016 Feb;174(2):177-86. doi: 10.1530/EJE-15-0775. Epub 2015 Nov 12.

PMID:
26563979
27.

Comparing the Hematopoetic Syndrome Time Course in the NHP Animal Model to Radiation Accident Cases From the Database Search.

Graessle DH, Dörr H, Bennett A, Shapiro A, Farese AM, MacVittie TJ, Meineke V.

Health Phys. 2015 Nov;109(5):493-501. doi: 10.1097/HP.0000000000000355.

PMID:
26425908
28.

Levothyroxine Treatment of Euthyroid Children with Autoimmune Hashimoto Thyroiditis: Results of a Multicenter, Randomized, Controlled Trial.

Dörr HG, Bettendorf M, Binder G, Karges B, Kneppo C, Schmidt H, Voss E, Wabitsch M, Dötsch J.

Horm Res Paediatr. 2015;84(4):266-74. doi: 10.1159/000437140. Epub 2015 Aug 7.

29.

DYNC2LI1 mutations broaden the clinical spectrum of dynein-2 defects.

Kessler K, Wunderlich I, Uebe S, Falk NS, Gießl A, Brandstätter JH, Popp B, Klinger P, Ekici AB, Sticht H, Dörr HG, Reis A, Roepman R, Seemanová E, Thiel CT.

Sci Rep. 2015 Jul 1;5:11649. doi: 10.1038/srep11649.

30.

Differential effects of low birthweight and intrauterine growth restriction on umbilical cord blood insulin-like growth factor concentrations.

Tzschoppe A, Riedel C, von Kries R, Struwe E, Rascher W, Dörr HG, Beckmann MW, Schild RL, Goecke TW, Flyvbjerg A, Frystyk J, Dötsch J.

Clin Endocrinol (Oxf). 2015 Nov;83(5):739-45. doi: 10.1111/cen.12844. Epub 2015 Jul 23.

PMID:
26118397
31.

Classic Congenital Adrenal Hyperplasia due to 21-Hydroxylase-Deficiency: 13 Years of Neonatal Screening and Follow-up in Bavaria.

Odenwald B, Dörr HG, Bonfig W, Schmidt H, Fingerhut R, Wildner M, Nennstiel-Ratzel U.

Klin Padiatr. 2015 Sep;227(5):278-83. doi: 10.1055/s-0035-1554639. Epub 2015 Jun 19.

PMID:
26090996
32.

Blood Pressure in a Large Cohort of Children and Adolescents With Classic Adrenal Hyperplasia (CAH) Due to 21-Hydroxylase Deficiency.

Bonfig W, Roehl FW, Riedl S, Dörr HG, Bettendorf M, Brämswig J, Schönau E, Riepe F, Hauffa B, Holl RW, Mohnike K; AQUAPE CAH Study Group.

Am J Hypertens. 2016 Feb;29(2):266-72. doi: 10.1093/ajh/hpv087. Epub 2015 Jun 11.

PMID:
26071487
33.

Short Children with CHARGE Syndrome: Do They Benefit from Growth Hormone Therapy?

Dörr HG, Boguszewski M, Dahlgren J, Dunger D, Geffner ME, Hokken-Koelega AC, Lindberg A, Polak M, Rooman R; KIGS International Board.

Horm Res Paediatr. 2015;84(1):49-53. doi: 10.1159/000382017. Epub 2015 May 29.

PMID:
26044035
34.

Long-term Surveillance of Children with Congenital Hypothyroidism: Data from the German Registry for Congenital Hypothyroidism (AQUAPE "Hypo Dok").

Ellerbroek VL, Bonfig W, Dörr HG, Bettendorf M, Hauffa B, Fricke-Otto S, Rohrer T, Reschke F, Schönau E, Schwab KO, Kapelari K, Röhl FW, Mohnike K, Holl RW.

Klin Padiatr. 2015 Jul;227(4):199-205. doi: 10.1055/s-0035-1549978. Epub 2015 Jun 3.

PMID:
26038964
35.

The placental mTOR-pathway: correlation with early growth trajectories following intrauterine growth restriction?

Fahlbusch FB, Hartner A, Menendez-Castro C, Nögel SC, Marek I, Beckmann MW, Schleussner E, Ruebner M, Huebner H, Dörr HG, Schild RL, Dötsch J, Rascher W.

J Dev Orig Health Dis. 2015 Aug;6(4):317-26. doi: 10.1017/S2040174415001154. Epub 2015 May 20.

PMID:
25989725
36.

Association of radiation-induced genes with noncancer chronic diseases in Mayak workers occupationally exposed to prolonged radiation.

Abend M, Azizova T, Müller K, Dörr H, Doucha-Senf S, Kreppel H, Rusinova G, Glazkova I, Vyazovskaya N, Unger K, Braselmann H, Meineke V.

Radiat Res. 2015 Mar;183(3):249-61. doi: 10.1667/RR13758.1. Epub 2015 Feb 23.

PMID:
25706777
37.

Spontaneous postnatal growth is reduced in children with CHARGE syndrome.

Dörr HG, Madeja J, Junghans C.

Acta Paediatr. 2015 Jul;104(7):e314-8. doi: 10.1111/apa.12980. Epub 2015 Mar 11.

PMID:
25703429
38.

[Quality of life of young adults after a growth hormone therapy with childhood onset].

Quitmann JH, Rohenkohl AC, Kammerer U, Schöfl C, Bullinger M, Dörr HG.

Dtsch Med Wochenschr. 2014 Nov;139(46):2335-8. doi: 10.1055/s-0034-1387314. Epub 2014 Nov 4. German.

PMID:
25369043
39.

MAP4-dependent regulation of microtubule formation affects centrosome, cilia, and Golgi architecture as a central mechanism in growth regulation.

Zahnleiter D, Hauer NN, Kessler K, Uebe S, Sugano Y, Neuhauss SC, Giessl A, Ekici AB, Blessing H, Sticht H, Dörr HG, Reis A, Thiel CT.

Hum Mutat. 2015 Jan;36(1):87-97. doi: 10.1002/humu.22711. Epub 2014 Nov 28.

PMID:
25323976
40.

Independent validation of candidate genes identified after a whole genome screening on Mayak workers exposed to prolonged occupational radiation.

Abend M, Azizova T, Müller K, Dörr H, Senf S, Kreppel H, Rusinova G, Glazkova I, Vyazovskaya N, Unger K, Meineke V.

Radiat Res. 2014 Sep;182(3):299-309. doi: 10.1667/RR13645.1. Epub 2014 Jul 30.

PMID:
25076116
41.

Naltrexone as a diagnostic tool to distinguish between hyperandrogenemic and hypothalamic ovarian failure in females with congenital adrenal hyperplasia due to 21-hydroxylase-deficiency (CAH).

Böttcher B, Dörr HG, Wildt L.

Eur J Obstet Gynecol Reprod Biol. 2014 Sep;180:153-6. doi: 10.1016/j.ejogrb.2014.06.007. Epub 2014 Jun 24.

PMID:
25065344
42.

Comparison of the needs for biodosimetry for large-scale radiation events for military versus civilian populations.

Swartz HM, Flood AB, Williams BB, Meineke V, Dörr H.

Health Phys. 2014 Jun;106(6):755-63. doi: 10.1097/HP.0000000000000069.

PMID:
24776910
43.

Threshold limits for biological indication of prolonged radiation exposure using mFISH.

Osovets SV, Sotnik NV, Meineke V, Scherthan H, Dörr H, Azizova TV.

Health Phys. 2014 Jun;106(6):677-81. doi: 10.1097/HP.0000000000000057.

PMID:
24776899
44.

Gene expression analysis in Mayak workers with prolonged occupational radiation exposure.

Abend M, Azizova T, Müller K, Dörr H, Senf S, Kreppel H, Rusinova G, Glazkova I, Vyazovskaya N, Schmidl D, Unger K, Meineke V.

Health Phys. 2014 Jun;106(6):664-76. doi: 10.1097/HP.0000000000000018.

PMID:
24776898
45.

Radiation exposure case management after incorporation of radionuclides.

Goulko G, Dörr H, Meineke V.

Health Phys. 2014 Jun;106(6):660-3. doi: 10.1097/HP.0000000000000084.

PMID:
24776897
46.
47.

[Cutaneous damage after acute exposure to ionizing radiation: decisive for the prognosis of radiation accident victims].

Dörr H, Baier T, Meineke V.

Hautarzt. 2013 Dec;64(12):904-9. doi: 10.1007/s00105-013-2626-x. German.

PMID:
24337305
48.

Linking the human response to unplanned radiation and treatment to the nonhuman primate response to controlled radiation and treatment.

Dörr H, Lamkowski A, Graessle DH, Bennett A, Shapiro A, Farese AM, Garofalo M, MacVittie TJ, Meineke V.

Health Phys. 2014 Jan;106(1):129-34. doi: 10.1097/HP.0b013e3182a12de0.

49.

Quality of survival and growth in children and young adults in the PNET4 European controlled trial of hyperfractionated versus conventional radiation therapy for standard-risk medulloblastoma.

Kennedy C, Bull K, Chevignard M, Culliford D, Dörr HG, Doz F, Kortmann RD, Lannering B, Massimino M, Navajas Gutiérrez A, Rutkowski S, Spoudeas HA, Calaminus G; PNET4 study group of the Brain Tumour Group of The European branch of the International Society of Paediatric Oncology (SIOP-E).

Int J Radiat Oncol Biol Phys. 2014 Feb 1;88(2):292-300. doi: 10.1016/j.ijrobp.2013.09.046. Epub 2013 Nov 13.

PMID:
24239386
50.

Two cases of thyroid dysgenesis caused by different novel PAX8 mutations in the DNA-binding region: in vitro studies reveal different pathogenic mechanisms.

Hermanns P, Grasberger H, Cohen R, Freiberg C, Dörr HG, Refetoff S, Pohlenz J.

Thyroid. 2013 Jul;23(7):791-6. doi: 10.1089/thy.2012.0141. Epub 2013 Jan 11.

Supplemental Content

Support Center